Moreover, the expression of 5'UTR TRPV1 variants in GBM, glioma stem-like cells (GSCs) and the 5'UTR TRPV1 variants role as prognostic factor in the survival of GBM patients have been evaluated. This evidence concerns the gene TRPV1 and glioma.